ScreenerHero

CELUCelularity Inc. Class A Common Stock

NAS · US · Healthcare · Biotechnology · celularity.com
0.8000USD+2.83%Mkt Cap: 23.16M $P/E: —

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBa…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap23.16M $
Enterprise Value91.04M $
Revenue (TTM)26.55M $
Gross Profit6.48M $
Net Income (TTM)-91.72M $
Revenue/Share1.037 USD
Last Price0.8000 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees115
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.35
PEG—
EV/EBITDA-1.69
EV/Revenue3.43
P/S0.84
P/B-0.58
EPS (TTM)-3.44
EPS (Forward)-0.57
52W Range
0.56016% of range4.310
52W High4.310 USD
52W Low0.5601 USD
Profitability
Gross Margin24.39%
Oper. Margin-492.15%
EBITDA Margin-203.44%
Profit Margin-345.45%
ROE240.96%
ROA-85.45%
Growth
Revenue Growth-77.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.25M $
CapEx (TTM)—
FCF Margin20.28%
FCF Yield23.25%
Net Debt68.54M $
Net Debt/EBITDA-1.27
Balance Sheet
Debt/Equity-1.07
Current Ratio0.15
Quick Ratio0.14
Book Value/Sh-1.3200 USD
Cash/Share0.2130 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateFeb 29, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.28.95M
Float18.87M
Insiders37.18%
Institutions12.88%
Short Interest
Short Ratio4.1d
Short % Float5.87%
Short % Out.1.35%
Shares Short390.84K
Short (prev mo.)413.40K
Technical
SMA 500.7201 (+11.1%)
SMA 2001.152 (-30.5%)
Beta0.54
S&P 52W Chg18.16%
Avg Vol (30d)40.95K
Avg Vol (10d)29.47K
Technical Indicators
RSI (14)60.9
MACD-0.0003
MACD Signal-0.0123
MACD Hist.+0.0120
BB Upper0.7969 USD
BB Middle0.7115 USD
BB Lower0.6261 USD
BB Width24.00%
ATR (14)0.0688 USD
Vol Ratio (20d)0.61x